The TEXAS Wake Up and Breathe Quality Improvement Initiative: Data Collection Activities Terri Conner, PhD Nybeck Analytics Project Manager Texas Wake.

Slides:

Advertisements

Similar presentations

Beyond VAP: Identifying areas for improvement to prevent ventilator-associated conditions Michael Klompas MD, MPH, FRCPC, FIDSA Harvard Medical School,

Advertisements

© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review Call in.

Sahar Elkaradawy Assistant Professor in Anaesthesia and Intensive Care Unite.

OUR LADY OF LOURDES MEMORIAL HOSPITAL Binghamton, New York Reducing Complications From Ventilators in ICU: Ventilator Associated Pneumonia (VAP)

©Copyright 2010 IHI/R. Lloyd Measurement Plan Worksheet VAP Measure NameType (Process, Outcome or Balancing) Driver addressed by this measure Operational.

University of DundeeSchool of Medicine Best practice in managing pneumonia: Scottish National Audit Project – Community Acquired Pneumonia (SNAP-CAP) Peter.

Ventilator-Associated Pneumonia. Introduction Definition 48 hours after intubation mechanically ventilated No clinical evidence of pneumonia prior to.

© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 NHSN VAE Surveillance Definition Review Presented by: Kathleen Speck,

Misericordia Hospital Edmonton, Alberta Delirium Collaborative.

The REDOXS © Study REducing Deaths from OXidative Stress PART 4 of 4 Sponsor Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD.

Case Report Form Start-up Meeting March 25, 2010 Kingston, ON.

Safer Healthcare Now! Ventilator Acquired Pneumonia Presented by Amanda Thompson, Safer Healthcare Now Facilitator April 12, 2007.

Reports: Daily Process, VAE, NHSN

Evelyn Mello, BSMT, (ASCP) MS, CIC Infection Control Practitioner.

1 Telligen Quality Innovation Network- Quality Improvement Organization Ventilator Associated Events –VAE June 26, 2015 This material was prepared by Telligen,

Ventilator-Associated Events: The Quest for Objectivity Presented by: Matthew B. Crist, MD, MPH.

Ventilator-Associated Events A Patient Safety Opportunity Michael Klompas MD, MPH, FRCPC, FIDSA, FSHEA Harvard Medical School, Harvard Pilgrim Health Care.

Measurement: the why, the what, and the how Paula Griswold, MPH Executive Director Massachusetts Coalition for the Prevention of Medical Errors Nora McElroy,

Unplanned Extubation in ICUs NR CNS III Outcomes Analysis Project December 3, 2013 Tania Randell, RN-BC, BSN.

Clinical Uses and Ramifications of VAE Data

Ventilator-Associated Events A Patient Safety Opportunity

Ventilator-associated events: a patient safety opportunity Michael Klompas MD, MPH, FRCPC, FIDSA Harvard Medical School, Harvard Pilgrim Health Care Institute,

CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Data Webinar 5 Defining the Early Mobility Measures ARMSTRONG INSTITUTE FOR PATIENT.

CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Infection Prevention 2 VAE Surveillance Training: Infectious Ventilator-Associated.

© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 CUSP for VAP: EVAP NHSN VAE Surveillance Definition Review Presented.

CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Content 1: Science of Safety & Identifying Defects ARMSTRONG INSTITUTE FOR PATIENT.

ความหมาย As Pneumonia in patient who have been on mechanical ventilation for greater than 48 hrs.

Prevention of BSI and VAP Measuring Change in Outcomes Part I Ted Speroff, PhD.

A PRACTICAL GUIDE FAYE DEAL, RN CIC LISA BROWN, MT(ASCP) CIC VAE.

Follow Up on Daily Xray for Intubated Patients Sebastian Benavides 12/10/2012.

Department of Critical Care Medicine Calgary Delirium Assessment and Treatment.

***Please note some slides have been removed since the webinar at the presenter’s request. CUSP for VAP Revisiting Your Action Plan: Using Reports to.

Overview of Agranulocytosis Stan Gerson, MD Chief, Division of Hematology & Oncology Asa & Patricia Shiverick Professor of Hematological Oncology University.

MLAB 2434 – CLINICAL MICROBIOLOGY SUMMER, 2005 CECILE SANDERS & KERI BROPHY Chapter 8 – Microscopic Examination of Infected Materials.

Infection Adjudication on REDCAP Module 1 Version: Feb 1st, 2012.

Spontaneous Awakening and Breathing Trials Brad Winters MD, PhD March 14, 2013.

Objective Outcomes Michael Klompas MD, MPH, FRCPC, FIDSA Harvard Medical School, Harvard Pilgrim Health Care Institute, and Brigham and Women’s Hospital,

Pain, Sedation and Delirium Collaborative

 How we collect data for SATs, SBTs, RASS and SAS  How has data collection affected our work flow  Have we made any improvements in patient care? 

Ventilator Associated Pneumonia (VAP)

1 Observations from Past Approvals for Acute Bacterial Sinusitis Janice Pohlman, M.D. AIDAC Meeting, October 29, 2003.

Sustaining Respiratory Therapist Engagement in ICU Liberation Tamra Kelly BS, RRT, Meg Blankinship MBA, BSRC, RRT, Alan Cubre MD, Kelly Switzler RRT, Latecia.

NYU Medical Grand Rounds Clinical Vignette Benjamin Eckhardt, MD PGY-3 October 6, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

Mini BAL v/s Bronchoscopic BAL PROF. PRADYUT WAGHRAY MD (CHEST), DTCD, FCCP (USA),D.SC(PULM. MEDICINE) HEAD OF DEPT. OF PULMONARY MEDICINE S.V.S MEDICAL.

1 Search and Rescue: The keys to Surviving Sepsis July 22, 2008 Emmel B. Golden, Jr., MD, ICU Medical Director Melanie Polzin, RN, CCRN, ICU Head Nurse.

CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Data Feedback: SubG ETT, Head of Bed Elevation and Delirium Assessment Utilization.

Context, Interpretation, Next Steps Linda Greene MS, RN Michael Klompas MD, MPH November 12, 2014 CUSP for Mechanically Ventilated Patients Interim Results.

© The Johns Hopkins University and The Johns Hopkins Health System Corporation, 2011 CSTS -VAP Prevention Data Collection Instructions Presented by Sean.

MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.

E A B C D Reducing Delirium in the ICU Patient: The ABCDE Bundle

VAP Rates – Critical Care January 1, 2010 – December 31, 2010.

Ventilator Associated Pneumonia. Ventilator-associated pneumonia (VAP) is a form of hospital-associated pneumonia (HAP) which develops in mechanically.

Effect of Pressure Support vs Unassisted Breathing Through a Tracheostomy Collar on Weaning Duration in Patients Requiring Prolonged Mechanical Ventilation.

VAE/VAP: Definitions, Algorithms and Best Practices

Weaning From Mechanical Ventilation

Monitoring Patients on Mechanical Ventilation: A New Paradigm Terri Conner, Ph.D. Nybeck Analytics May 2012.

Comparison between pathogen directed antibiotic treatment and empiri cal broad spectrum antibiotic treatment in patients with community acquired pneumonia.

TIPS FOR COMPLETING CRF’S October Antimicrobial Report Form 7  In iDataFax use the drop-down list to record the Antimicrobial Code. This will.

Pattern of Hospital-Acquired Pneumonia in Intensive Care Unit of Suez Canal University Hospital By Nermine El-Maraghy Associate Professor of Medical Microbiology.

Misericordia Hospital Edmonton, Alberta

MEASURE(S)/OUTCOME(S)

CUSP for Mechanically Ventilated Patients

CUSP 4 MVP – VAP Improving Care for Mechanically Ventilated Patients Infection Prevention 3 VAE Surveillance Training: Possible VAP (PVAP) APRV and.

Nibble The Importance of Nutritional Adequacy

CUSP 4 MVP-VAP Data Facilitator Discussion – 1

ABCDEF Checklist Instructions:

ABCDEF Checklist Instructions:

ABCDEF Checklist Instructions:

CUSP 4 MVP-VAP IP VAE Surveillance, Call – 3

ABCDEF Checklist Instructions:

Presentation transcript:

The TEXAS Wake Up and Breathe Quality Improvement Initiative: Data Collection Activities Terri Conner, PhD Nybeck Analytics Project Manager Texas Wake Up and Breathe Initiative 1

Overall Initiative Purpose Improve care for ventilated patients – Improve sedative weaning – Speed extubation 2

Results of Observation Studies Audits from across the country show that Spontaneous awakening trials (SATs) and Spontaneous breathing trials (SBTs) are only initiated 50% of the time SBTs not coordinated with SATs 3

Benefits of coupled SATs and SBTs time on ventilation up to 3 days time in hospital up to 4 days 4

Texas Wake Up and Breathe Collaborative Structure Designate champion Baseline survey – Please complete this at your earliest convenience and return to Terri Conner at Monthly data submission and surveys Monthly calls with our group 5

Three tools Monthly survey Daily data collection tool Monthly data submission

Monthly Survey All Teach, All Learn Aim Tests conducted Outcomes Lessons learned Barriers / breakthroughs Plans for next month 7

Data Collection Efforts Track performance Measure impact on outcomes – LOS – Mortality – Antibiotic usage – VAC, IVAC, VAP rates 8

SAT/SBT Performance Documentation Clinical champions should oversee SAT/SBT documentation Integrate into existing processes – Daily care plans – Checklists Develop your own process 9

Daily Data Elements Excel spreadsheet tool Automatic calculation – VAC – IVAC Possible and probable VAP 10

Outcome Definitions VAC – Significant respiratory deterioration after >2 days of stability IVAC – VAC – abnormal temp or WBC count – >4 days of new antibiotics 11

Outcome Definitions Possible VAP – IVAC – Either purulent sputum OR + sputum/BAL culture Probable VAP – IVAC – Both purulent sputum AND + sputum/BAL culture 12

Daily Data Collection VAC Status PatientDatePEEPminFiO2minVAC 11-Apr Apr Apr Apr

Daily Data Collection VAC Status PatientDatePEEPminFiO2minVAC 11-Apr Apr Apr-12950VAC 14

Daily Data Collection IVAC Status Tmin, Tmax, WBCmin, WBCmax – Enter for a total of 5 days – Start 2 days prior to VAC onset 15

Daily Data Collection IVAC Status PtDateT min T max WBC min WBC max QADSig Temp Sig WBC QAD Flag IVAC 11-Apr Apr Apr Apr 15-Apr 16

Daily Data Collection IVAC Status PtDateT min T max WBC min WBC max QADSig Temp Sig WB C QAD Flag 13- Apr Yes 17

Daily Data Collection QAD Determination QAD – New antibiotic prescribed or continued – Includes days between doses at extended intervals (> q 24 h) – Data are entered for up 10 days (4 days before VAC, on the VAC dx day, and 5 days after VAC) 18

Antibiotic Worksheet QAD Determination Dose hour VAC day Levo24YY VancYY level Y 19

Antibiotic Worksheet QAD Determination PtDose hour VAC day Levo24YY VancYYY level Y QADXXXXXXX 20

Daily Data Collection IVAC Status PtT min T max WBC min WBC max QADSig Temp Sig WBC QAD Flag IVAC Yes113IVAC 21

Daily Data Collection Possible/Probable VAP Status Enter sputum/BAL gram stain and culture results – Polys – Epis – Culture – Growth > Threshold 22

Daily Data Collection Possible/Probable VAP Status PatientDatePolysEpisCultureGrowth > Threshold 11-Apr Apr-1222 Enterococcus 13-Apr-1221 Klebsiella Yes 23

Daily Data Collection Possible/Probable VAP Status POLYS – Sputum or BAL gram stain polymorphonucleated cells, neutrophils, or white blood cells – Enter 0 to 4 0: none 1: few, rare, <10 cells/lpf 2: moderate, >25 cells/lpf 3: many 4: abundant 24

Daily Data Collection Possible/Probable VAP Status EPIS – Sputum or BAL gram stain epithelial cells or squamous cells – Enter 0 to 4 0: none 1: few, rare, <10 cells/lpf 2: moderate, >25 cells/lpf 3: many 4: abundant 25

Daily Data Collection Possible/Probable VAP Status PatientDatePolysEpisCultureGrowth > Threshold 11-Apr Apr-1222 Enterococcus 13-Apr-1221 Klebsiella Yes 26

Daily Data Collection Possible/Probable VAP Status PatientDatePolysEpisCultureGrowth > Threshold 11-Apr Apr Apr

Daily Data Collection Possible/Probable VAP Status CULTURE – Enter the culture result Growth > Threshold – Yes > 10 5 CFU/mL for endotracheal aspirate > 10 4 CFU/mL for BAL > 10 3 CFU/mL for protected specimen brush Semi-quantitative equivalents also acceptable 28

Daily Data Collection Possible/Probable VAP Status PatientDatePolysEpisCultureGrowth > Threshold 11-Apr Apr-1222 Enterococcus 13-Apr-1221 Klebsiella Yes 29

Daily Data Collection Possible/Probable VAP Status PatientDatePolysEpisCultureGrowth > Threshold 11-Apr Apr-1222 Enterococcus 13-Apr-1221 Klebsiella Yes 30

Daily Data Collection Possible/Probable VAP Status PatientDatePossible VAP Probable VAP Final Determination 11-Apr Apr Apr-12Probable VAP 31

Monthly Data Report Hospital LOS ICU LOS Hospital discharge status Ventilator days SAT days – ‘real time’ data collection SBT days - ‘real time’ data collection Self-extubated / re-intubated (optional) Outcomes (VAC,IVAC, poss/prob VAP) 32

Monthly Data Report 33

Questions? Repeat webinar on July 16 th, 9am CT Please feel free to contact Terri at or Rachel at 34